Thrombosis and Cancer Immunotherapy: The Next Frontier of Thromboinflammation

Thrombosis and Cancer Immunotherapy The Next Frontier of Thromboinflammation Review Abstract Cancer immunotherapy has fundamentally transformed the treatment landscape across multiple malignancies, offering durable responses and prolonged survival in patients with previously limited therapeutic options. Immune checkpoint inhibitors, chimeric antigen receptor T cell therapies, bispecific antibodies,

Controversies in Antiphospholipid Syndrome: DOACs vs. Warfarin

Controversies in Antiphospholipid Syndrome: DOACs vs. Warfarin  Check out our extensive video library (see channel for our latest videos) Abstract Antiphospholipid syndrome (APS) represents a complex autoimmune disorder characterized by thrombotic events and pregnancy complications in patients with persistent antiphospholipid antibodies. The traditional anticoagulant

Thrombosis and Cancer Immunotherapy: The Next Frontier of Thromboinflammation